<DOC>
	<DOCNO>NCT02832622</DOCNO>
	<brief_summary>This prospective , multicenter , non-randomized registry/observational study . The study enroll 2,000 patient successful St. Jude Medical ( SJM ) Cardiac Resynchronization Therapy ( CRT ) MP device implant 140 center undergoing CRT implantation .</brief_summary>
	<brief_title>MultiPoint Pacingâ„¢ Post Market Study</brief_title>
	<detailed_description>Any patient received market approve SJM Quadra Allure MP , Quadra Assura MP , new SJM CRT MP device eligible enrollment study . MultiPoint Pacing ( MPP ) program guidance specify protocol . Patients follow 12 month implant . Data collect Baseline ( within 30 day prior implant ) , Post-Implant ( within 30 day follow successful CRT device implant ) , 3 , 6 , 12 month unscheduled follow-up visit .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Are schedule receive new CRT implant upgrade exist implantable cardioverter defibrillator pacemaker implant ( SJM CRT MP device SJM Quadripolar Lead ) prior leave ventricular lead placement Have ability provide inform consent study participation willing able comply prescribe followup test schedule evaluation Are expect receive heart transplant duration study Have epicardial ventricular lead system ( Active Inactive ) Are le 18 year age Are currently participate clinical investigation include active treatment arm belong active arm Are expect complete study followup schedule duration due health condition heart failure , malignancy , indication heart transplant hospice care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>MultiPoint Pacing</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>SJM Quadripolar Biventricular Pacing</keyword>
</DOC>